PubMed · 40803
Do neuroleptics prevent the penetration of dopamine agonists into the brain?
Abstract
A new, specific and highly sensitive method for the determination of apomorphine based on high performance liquid chromatography on a C18 reverse-phase column, coupled with electrochemical detection has been developed. The limit of detection of the assay is approximately 0.5 ng/sample (2 pmol). Haloperidol, cis-flupenthixol, metoclopramide and reserpine prevented the accumulation of apomorphine equally in "dopaminergic" as well as in "non-dopaminergic" brain areas. The non-neuroleptic trans-isomer of flupenthixol was without effect. Suppression of the accumulation of the dopamine agonist 6,7-ADTN (administered as the prodrug dibenzoyl-6,7-ADTN) was seen after combined treatment with haloperidol or reserpine, whereas cis- and trans-flupenthixol were without effect. The results imply that certain behavioural, biochemical and neuropharmacological studies, based on apomorphine in combination with other drugs, may need reinterpretation.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
B H Westerink, A S Horn. 1979-09-01. Do neuroleptics prevent the penetration of dopamine agonists into the brain?. https://doi.org/10.1016/0014-2999(79)90337-6
Cite the original work for its findings. Save a collection to share your selection of sources.